Evidence map›Paper›PMID 25753045›Full record

ArticleJournal of cellular and molecular medicine2015

Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients.

Simone E Barry, Brian Chan, Magda Ellis, YuRong Yang, Marshall L Plit, Guangyu Guan, Xiaolin Wang, Warwick J Britton, Bernadette M Saunders

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Targets and regulation of microRNA-652-3p in homoeostasis and disease.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Simone E BarryCentenary Institute, Newtown, NSW, Australia.
Brian ChanCentenary Institute, Newtown, NSW, Australia.
Magda EllisCentenary Institute, Newtown, NSW, Australia.
YuRong YangNingxia Medical University, Yinchuan, Ningxia, China.
Marshall L PlitDepartment of Thoracic Medicine St Vincent's Hospital, Darlinghurst, NSW, Australia.
Guangyu GuanNingxia Centre for Disease Control and Prevention, Yinchuan, Ningxia, China.
Xiaolin WangInfectious Disease Hospital of Ningxia, Yinchuan, China.
Warwick J BrittonCentenary Institute, Newtown, NSW, Australia.
Bernadette M SaundersCentenary Institute, Newtown, NSW, Australia.
Centenary Institute · AUNingxia Center for Diseases Prevention and Control · CNSt. Vincent's Birmingham · USUniversity of Sydney · AUNingxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) remains a major public health issue. New tests to aid diagnoses and monitor the response to therapy are urgently required. There is growing interest in the use of microRNA (miRNA) profiles as diagnostic, prognostic or predictive markers in a range of clinical and infectious diseases, including Mycobacterium tuberculosis infection, however, challenges exist to accurately normalise miRNA levels in cohorts. This study examined the appropriateness of 12 miRs and RNU6B to normalise circulating plasma miRNA levels in individuals with active TB from 2 different geographical and ethnic regions. Twelve miRs (let-7, miR-16, miR-22, miR-26, miR-93, miR-103, miR-191, miR-192, miR-221, miR-423, miR-425 and miR-451) and RNU6B were selected based on their reported production by lung cells, expression in blood and previous use as a reference miRNA. Expression levels were analysed in the plasma of newly diagnosed TB patients from Australia and China compared with individuals with latent TB infection and healthy volunteers. Analysis with both geNorm and NormFinder software identified miR-93 as the most suitable reference miR in both cohorts, either when analysed separately or collectively. Interestingly, there were large variations in the expression levels of some miRs, in particular miR-192 and let-7, between the two cohorts, independent of disease status. These data identify miR-93 is a suitable reference miR for normalizing miRNA levels in TB patients, and highlight how environmental, and possibly ethnic, factors influence miRNA expression levels, demonstrating the necessity of assessing the suitability of reference miRs within the study population.

Indexed as

AdolescentAdultAgedAustraliaCase-Control StudiesCohort StudiesFemaleGene Expression RegulationGenetic Association StudiesHumansMaleMicroRNAsMiddle AgedReference StandardsSoftwareTuberculosisMicroRNAsMIRN93 microRNA, humanmicroRNAnormalisationplasmarespiratory diseasetuberculosis

Identifiers

PMID25753045
PMCPMC4511358
OpenAlexW2039775293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.